PDH-E1 Antibodies

Santa Cruz Biotechnology features a diverse variety of PDH-E1 monoclonal antibodies for research focused on understanding the pyruvate dehydrogenase complex in cellular metabolism. PDH-E1 monoclonal antibodies are suitable for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PDH-E1 serves as a crucial component of the pyruvate dehydrogenase complex, catalyzing the conversion of pyruvate into acetyl-CoA, which connects glycolysis to the citric acid cycle. This conversion process plays a fundamental role in energy production and metabolic regulation within cells. Abnormal PDH-E1 function can result in metabolic disorders and is associated with various diseases, including cancer and neurodegenerative conditions. Understanding PDH-E1's role in metabolism has become increasingly important in both basic research and therapeutic development. Investigating PDH-E1 function helps reveal the complexities of cellular energy production and its impact on various physiological processes. Research utilizing PDH-E1 monoclonal antibodies continues to advance our knowledge of metabolic regulation and disease mechanisms. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of cellular metabolism and its role in health and disease.